Latest Asx Company Filings News

Goodman Group delivered a robust half-year performance with operating profit up 8.4% and statutory profit swinging to a $799.8 million gain. The industrial property giant also announced a $4 billion equity raise to fuel its expanding data centre and logistics developments.

Cleanaway Waste Management Limited reported a robust first half of FY25 with double-digit EBIT growth and margin expansion, reinforcing confidence in meeting FY25 guidance and ambitious FY26 targets despite operational challenges.

Corporate Travel Management Limited reported strong half-year results for the period ending December 31, 2024, with significant EBITDA growth and effective capital management, returning $52.3 million to shareholders. The company sets ambitious FY25 and FY26 targets focused on sustainable profit growth and market share expansion.

Corporate Travel Management delivered robust first-half results led by ANZ and North America, while previewing ambitious FY26 targets to double EPS within five years.

Corporate Travel Management Limited (CTM) reported a 42% drop in net profit for the half-year ended December 2024, amid a 6% revenue decline. Despite this, strong performances in North America and Australia & New Zealand, alongside ongoing automation and new client wins, position CTM for a rebound in the second half.

EBOS Group Limited’s interim results for H1 2025 reveal a notable decrease in revenue and profit compared to the prior year, yet the company maintains its interim dividend, signaling confidence despite headwinds.

EBOS Group Limited posted robust interim results for H1 FY25, with underlying EBITDA rising 7.1% excluding the Chemist Warehouse Australia contract, driven by strong organic growth and strategic investments. The company maintained its dividend and reiterated FY25 EBITDA guidance between $575 million and $600 million.

EBOS Group Limited posted a strong half-year performance with underlying EBITDA up 7.1% to $291 million, driven by growth in healthcare and animal care segments, while maintaining its interim dividend amid the loss of the Chemist Warehouse contract.

EBOS Group Limited has reported a 9% drop in revenue and an 18.9% fall in net profit for the first half of fiscal 2025, yet it maintains its interim dividend at 57 NZ cents per share.

Brisbane Broncos Limited has announced a fully franked ordinary dividend of AUD 0.02 per share for the 2024 financial year, signaling steady returns for shareholders.

Atturra Limited reports a robust first half of FY25 with revenue growth nearing 28%, driven by recent acquisitions and expanding service offerings, while updating full-year guidance amid cautious government sector risks.

Zelira Therapeutics has received a $1.15 million cash refund from the Australian Government’s R&D Tax Incentive Scheme, bolstering its working capital to advance clinical development and business operations.